You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Baxter
Harvard Business School
Express Scripts
Boehringer Ingelheim

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Patent: 6,713,662

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,713,662
Title: Production of collagen in the milk of transgenic mammals
Abstract:The invention provides transgenic nonhuman mammals capable secreting exogenous procollagen or collagen into their milk. The mammals are healthy and capable of producing procollagen or collagen at high levels, usually in trimeric form. Suitable transgenes for incorporation into the mammals are also provided.
Inventor(s): Karatzas; Costas N. (Beaconsfield, CA), Pieper; Frank (Utrecht, NL), De Wit; Ineke (Leiden, NL), Berg; Richard (Los Altos, CA), Platenburg; Gerard (Voorschoten, NL), Toman; Paul David (Mountain View, CA)
Assignee: Pharming Intellectual Property B.V. (Leiden, NL) Cohesion Technologies (Palo Alto, CA)
Application Number:08/482,173
Patent Claims:see list of patent claims

Details for Patent 6,713,662

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Pharming Intellectual Property B.V. (Leiden, NL) Cohesion Technologies (Palo Alto, CA) 2021-03-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Pharming Intellectual Property B.V. (Leiden, NL) Cohesion Technologies (Palo Alto, CA) 2021-03-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Pharming Intellectual Property B.V. (Leiden, NL) Cohesion Technologies (Palo Alto, CA) 2021-03-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Harvard Business School
McKinsey
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.